(Q52130503)

English

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

scientific article published in November 1966

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

cerebrospinal fluid

0 references

0 references

author name string

G W Ashcroft

1

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

T B Crawford

2

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

D Eccleston

3

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

D F Sharman

4

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

E J MacDougall

5

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

J B Stanton

6

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

J K Binns

7

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

language of work or name

0 references

publication date

1 November 1966

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

2

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

7472

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

1049-1052

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

5-Hydroxyindoles in Human Cerebrospinal Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in amine metabolism produced by antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tryptamine metabolism in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on sodium transfer and 5-hydroxyindoles in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and Characterization of a Compound from the Urine of Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of monoamine oxidase inhibitors on the level of 5-hydroxyindoleacetic acid in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2992028-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(66)92028-9

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/4162505

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52130503&oldid=1398687801"